Heart to Heart: Cardiovascular Considerations in Type 2 Diabetes – Mainpro+

Upon completion of this program, participants will be able to:

1. Discuss the relationship between diabetes, microvascular and macrovascular outcomes and the importance of glycemic control.
2. Relate the rationale behind the diabetes CV safety outcome trials (CVOT).
3. Differentiate between the cardiovascular endpoints seen in the different antihyperglycemic agent CV outcome trials and their implications for practice.
4. Describe how intensive glucose control reduces the risk of microvascular complications in patients with type 2 diabetes.
5. Explain the importance of individualizing treatment for patients with type 2 diabetes.